Tumutud, Breant M.

HRN: 17-91-66  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/04/2022
CEFUROXIME 500MG (TAB)
04/04/2022
04/11/2022
IVTT
500MG
Q8
PUS CELLS 4-6

 Indication:  Empiric    Type of Infection:  Urinary Tract    Compliance to guidelines: Non-compliant To Guidelines